Praise for Biolocity


“Biolocity provided critical expertise and resources to move our technology forward. The advising structure and advice on commercialization have been invaluable is a very unique strength of the program.”
– Andrés J. García, PhD, FBSE, Executive Director, Parker H. Petit Institute for Bioengineering and Bioscience

 

“Biolocity enabled us to receive an FDA 510(k) clearance on our first generation product. We couldn’t have done it without the support of Biolocity.”

– Erika Tyburski, AnemoCheck

 
“The Biolocity team provided invaluable assistance that moved our project from an NIH focus to a commercial venture. They recognized the value of our technology and how to promote it to industry. We would not have succeeded without their expertise.”

– Jeff M. Sands, MD, Renal Division Director, Emory University

 
“As a scientist without formal business training, I had no idea how to speak with Venture Capitalists or create an appropriate pitch deck. The Biolocity team helped me learn these valuable skills.”

– James Dahlman, PhD Assistant Professor, Department of Biomedical Engineering, Georgia Institute of Technology & Emory School of Medicine

 
“We applied with the idea that funding would be the primary determinant necessary for our success.  What we learned is that the guidance, advocacy, mentorship, and regulatory resources received were every bit as critical.  Our team is profoundly grateful to the Biolocity team for their guidance in translating a technical idea into a real world clinical resource that will soon benefit patients.”

– Frank Tong, MD, Assistant Professor, Neurosurgery, Emory University

 
“Biolocity has truly enabled me to pursue dreams that would otherwise have been impossible. I never knew I could do so much with an idea and I feel much more knowledgeable with Biolocity guiding me through the process.”

– Andrea Joyner, MD, IBCLC, Assistant Professor of Obstetrics and Gynecology, Emory University